Eczema Awareness Monthly – An American Academy of Dermatology Official Licensee
0
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
0
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Advertisement
EczemaStudies

Difamilast as a treatment for pediatric atopic dermatitis

Awareness Monthly
Posted by Awareness Monthly

The efficacy and safety of difamilast, a topical PDE4 inhibitor, is analyzed for the treatment of atopic dermatitis in pediatric patients.

Learn more at the Journal of the American Academy of Dermatology.

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Awareness Monthly
Previous Article Pharmacological activity of difamilast, a novel PDE4 inhibitor for the topical treatment of atopic dermatitis
Next Article The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis

Leave a Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Advertisement

 

Advertisement

 

You Might Also Enjoy

EczemaStudies

Examining the Use of Systemic Immunomodulating Medications in Pregnant Women with Atopic Dermatitis

EczemaStudies

Exploring the Risk of Skin Cancer from Ultraviolet B Phototherapy for the Treatment of Atopic Dermatitis

EczemaStudies

Atopic Dermatitis: Review Provides an Updated Overview of Emerging Treatments for Itch

EczemaStudies

Researchers Seek to Uncover the Impact of Atopic Dermatitis on Alopecia Areata

Load More
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee

© 2020-2023 Powered by eHealthcare Solutions | Privacy Policy

×